Search

Author/Creator Lin, Liwang

1. Characteristics and clinical influence factors of arsenic species in plasma and their role of arsenic species as predictors for clinical efficacy in acute promyelocytic leukemia (APL) patients treated with arsenic trioxide. Issue 4 (3rd April 2021)

Authors:
Guo, Meihua; Zhou, Jin; Fan, Shengjin; Li, Limin; Chen, Hongzhu; Lin, Liwang; Zhao, Qilei; Wang, Xinyu; Liu, Wensheng; Wu, Zhiqiang; Hai, Xin
Journal:
Expert review of clinical pharmacology
Issue:
Volume 14:Issue 4(2021)
Page Start:
503
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Characteristics of arsenic species in cerebrospinal fluid (CSF) of acute promyelocytic leukaemia (APL) patients treated with arsenic trioxide plus mannitol. Issue 10 (20th March 2021)

Authors:
Guo, Meihua; Zhao, Qilei; Fan, Shengjin; Wu, Zhiqiang; Lin, Liwang; Chen, Hongzhu; Gao, Yanhui; Hai, Xin
Journal:
British journal of clinical pharmacology
Issue:
Volume 87:Issue 10(2021)
Page Start:
4020
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Effect of renal impairment on arsenic accumulation, methylation capacity, and safety in acute promyelocytic leukemia (APL) patients treated with arsenic trioxide. Issue 9 (2nd September 2021)

Authors:
Zhao, Qilei; Guo, Meihua; Hostetter, Thomas H.; Chen, Hongzhu; Lin, Liwang; Hai, Xin
Journal:
Expert review of clinical pharmacology
Issue:
Volume 14:Issue 9(2021)
Page Start:
1173
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗